Community-reported insights only, not medical advice. Data recency varies by source; check timestamps and confidence before making treatment decisions.

← Back to Brands

DOE

Community footprint analysis based on portfolio size and patient feedback.

Time Period:
Rank
6
Portfolio
2 Strains
Mentions (90d)
6
Brand Score (90d)
74
vs Market Avg: 64 vs All Time: 63
Performing Well

Rating higher than the 90d community baseline.

Medication Portfolio (2)

Rank Strain Name Specs Mentions (90d) Score (90d) Historical Avg
16
27.0% Yes
3
76
62
92
Britz
27.0%
3
72
65